Retention clinical trials

Explore recruiting retention clinical trials.

Recruiting retention studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Retention trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomised, multi-centre, intra-patient imaging and dosimetry crossover study of lutetium (177Lu) rhPSMA-10.1 and lutetium (177Lu) vipivotide tetraxetan (Pluvicto®) in patients with non-curative metastatic prostate cancer

Spain, Germany, France, Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Characterization of cerebral tau aggregates with 18F-RO6958948 PET in the ALFA population

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Pilot study on the safety and feasibility of intravenous opioid agonist therapy (OAT) with Hydagelan® (hydromorphone hydrochloride) in Vienna.

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Combination Compared to Zibotentan Monotherapy as well as Zibotentan/Dapagliflozin and Zibotentan Monotherapy Compared to Placebo in Participants with Cirrhosis

Belgium, Slovakia, Czechia, Germany, Italy, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

MOTHER trial: Efficacy and safety of low-dose intrathecal morphine following planned caesarean section - a randomised, blinded, clinical, controlled, multicentre trial.

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

(REGON) Repeated corticosteroid injections around the Greater Occipital Nerve (GON) as prophylactic treatment in chronic cluster headache

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Retention trials by city

Retention in Toronto Retention in Vancouver Retention in Montreal Retention in Calgary Retention in Edmonton Retention in Ottawa Retention in Winnipeg Retention in Quebec City Retention in Hamilton Retention in Kitchener Retention in London Retention in Halifax Retention in New York Retention in Los Angeles Retention in Chicago Retention in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease